Paradigm secures USD $27M to fully fund its global Phase 3 OA trial through interim analysis.
Join today’s investor webinar at 11:30 am AEST:
us02web.zoom.us/webinar/regist…
Today, Paradigm Biopharmaceuticals announced the acquisition of Proteobioactives, securing global rights to a patented oral combination of PPS and a COX-2 inhibitor, targeting early-stage osteoarthritis in both humans and animals.
Read more here: cdn-api.markitdigital.com/apiman-gateway…
This stock could have something close to a cure for #osteoarthritis. Don’t let it hide under your nose
Paradigm Biopharmaceuticals (#ASX: $PAR) Managing Director Paul Rennie spoke with The Market Online to discuss further >
Find out more: hotcopper.com.au/news/asx-news/…@ParadigmBio
We’ve secured centralised US ethics approval for our Phase 3 trial of iPPS in knee osteoarthritis. A significant step in expanding our clinical program and advancing a first-in-class treatment for millions. See Paul Rennie’s comments & full ASX release:cdn-api.markitdigital.com/apiman-gateway…
Last week, Paradigm presented at the Ignite Investment Summit in Hong Kong.
We had incredible engagement from leading family offices across Asia. The strong interest in our phase 3 OA program reaffirms Paradigm as a standout late-stage biotech opportunity.
#IgniteConference
Paradigm clear to proceed to our pivotal phase three clinical trial in knee osteoarthritis.
This is a significant milestone for the company. The team now shifts their focus to the start-up activities to initiate patient enrolment.
Read more: cdn-api.markitdigital.com/apiman-gateway…
Paradigm's 2024 Annual Report has been released.
Key Highlights:
- iPPS shows 12-month efficacy
- Structural improvements seen at six months
- PARA_OA_002 Stage 1 completed
Read the full report: cdn-api.markitdigital.com/apiman-gateway…
Founder and MD, Paul Rennie, presented Paradigm's clinical progress and exciting data to the Bioshares Biotech Summit in Fremantle last week. We would like to thank Mark Pachacz and the wider Bioshares team for the opportunity to present and an outstanding conference.
$PAR #ASX
Managing Director, Paul Rennie, will be presenting at the upcoming 18th Bioshares Biotech Summit on Friday 12 July, in Fremantle, Western Australia.
$PAR #KneeOA#osteoarthritis#pentosan#PPS
#ASX#biotech companies are gunning for US #FDA approval as that not only validates the safety and efficacy of a new drug, but also offers commercial opportunities. bit.ly/4blDSrJ
Today, we celebrate the achievements of women worldwide, including the incredible contributions of the women at Paradigm. Your dedication is helping to shape the future of care for those suffering from osteoarthritis. Thank you for your invaluable impact on the organisation.
Arthritis Australia's Senate Inquiry appearance in Feb, spotlighted challenges faced by arthritis patients amid rising costs. CEO Jonathan Smithers stressed staggering out-of-pocket expenses, urging for change and new treatments. Read more: mailchi.mp/arthritisaustr… $PAR
19K Followers 867 FollowingInvestor & Trader. My tweets are all IMHO & may impact the price of stock. DYOR. Not a licensed financial advisor. I may sell parcels of stock into the strength
15K Followers 10K Followingequities | current affairs | critical minerals | clean energy l energy storage | tech | Information, views and opinions provided are general in nature.
4K Followers 1K FollowingWA thoroughbreds with gate speed and a bit of ticker | Data enthusiast | Form Analyst for @CrippsRacing service 🐎 Overall +312.19u @ 13.9% PoT | Website below
26K Followers 1K FollowingSmall Caps is Australia's #1 site for market news & information on ASX listed small cap companies.
Newsletter: https://t.co/6Y8mZeyPwH
16K Followers 556 FollowingWe lead the world in up-to-the-minute, multi-media news provision.
We receive compensation for publishing content here on behalf of our clients. T&Cs apply
4K Followers 683 FollowingServing up fresh finance news, market movers and expertise.
Meet the CEOs of ASX-listed companies via our free weekly investor events.
200 Followers 2K FollowingDengYueMed is a licensed leader in importing and exporting specialty drugs for chronic diseases, proudly licensed by the Department of Health.
485 Followers 99 FollowingRetired, living in south-west Western Australia. $TSLA investor and follower. 40 years serious competitive swimmer; now just for fun... plus yoga, gym, art.
110 Followers 1K FollowingBiopharma Bytes stands at the forefront of transforming how professionals digest the latest developments in biopharmaceuticals - one byte at a time.
34 Followers 431 FollowingRemedy & Company (Global CRO) is a company based in Japan that focuses on providing innovative solutions within the healthcare and pharmaceutical industries.
14 Followers 386 FollowingPartner with https://t.co/e6whGYBmBC Genome Research Institute, we are building an International Network of Ideas, solutions and partnerships in the BioPharm community.
16K Followers 556 FollowingWe lead the world in up-to-the-minute, multi-media news provision.
We receive compensation for publishing content here on behalf of our clients. T&Cs apply
18K Followers 1K FollowingOfficial feed for latest news and info about the Australian Government's commitments and investments in science. Retweets are not endorsements.
9K Followers 846 FollowingThe national grassroots voice for people living with chronic pain. Non profit health promotion charity established in 2001. https://t.co/DAPxsmGB1v
407 Followers 105 FollowingOffering readers a deeper exploration and understanding of the relationships between service providers and their Bio and Pharma sponsors.
66K Followers 101 FollowingScience Advances is an open access journal from AAAS that publishes innovative original research across all disciplines of science freely to a global audience.
5K Followers 1K FollowingOT and Me aims to support every Canadian learning about Occupational Therapy and how Occupational Therapists can promote health and wellbeing.
387 Followers 204 FollowingUpdates from the Orthopaedic and Arthritis Center for Outcomes Research (OrACORe) and Policy and Innovation eValuation in Orthopaedic Treatments (PIVOT) Center.
306 Followers 496 FollowingMary Link Briggs Distinguished Professor of Medicine, Associate Center Director of Thurston Arthritis Research Center, Director of OA Action Alliance.
3K Followers 3K FollowingMed Device Executive | 3x HOF Award Winner | Top 50 Influencer in Digital Orthopedics | Top 15 Orthopedic Blog #3Dprinting #RoboticSurgery #AR #GenAI #wearables
13K Followers 846 FollowingLive streaming business & markets news and views from 9:45am AEST. Get 'the COB' newsletter delivered featuring our 'stock of the day': https://t.co/1k9SLoEb9w
2K Followers 535 FollowingWe exist to improve knowledge, choice & connection that drive positive outcomes for people impacted by musculoskeletal conditions.
3K Followers 2K FollowingArthritis Australia is dedicated to bringing quality of life to all people with arthritis and other musculoskeletal conditions.
2K Followers 448 FollowingProfessor, researcher, physiotherapist; helping people live better with #osteoarthritis @CHESM_unimelb @UniMelbMDHS. Wife, mum, dog owner, friend. Views my own.
31K Followers 1K FollowingAn international leader in medical and scientific training, biomedical research, and patient care. It is the medical school for @MountSinaiNYC.
9K Followers 1K FollowingThe Stock Market Newsletter for Self Directed Investors. Sign up for a free trial and explore our new website - https://t.co/E6VHnuFXPU 📈🗞️
5K Followers 2K FollowingThe Foundation for the National Institutes of Health (FNIH) builds and nurtures scientific partnerships to make important health discoveries possible.
50K Followers 1K FollowingThe AAOS is the world’s largest medical association of musculoskeletal specialists and your trusted source for orthopaedic information.
16K Followers 1K FollowingBreaking news, patient stories & FDA updates within the rare disease community. Listen to our podcast: https://t.co/xUkFDfCDUV, hosted by @GiulianaGrossi
42K Followers 3K Following29 February 2024 is Rare Disease Day. Raising awareness for patients, families and carers around the world that are affected by rare diseases. #RareDiseaseDay
40K Followers 3K Following#NORD has been the voice of the U.S. #RareDisease community for 40+ years strong. Official U.S. sponsor of #RareDiseaseDay. On Bluesky at @ https://t.co/D7PIT4k0Py
806K Followers 47 FollowingOfficial account for the latest company news and updates from Asset Management, Private Banking, and the Commercial and Investment Bank.
69K Followers 92 FollowingOfficial account of the U.S. Patent and Trademark Office. Leading the nation and the world in intellectual property protection and policy.
57K Followers 668 FollowingProfessor, Curtin University, Specialist PT, Evoolvepaincare. academy Bridging research and practice to empower clinicians & people in pain.
241K Followers 1K FollowingOfficial feed of NICE - National Institute for Health and Care Excellence. We produce evidence-based health and social care guidance. Tweets by the comms team.
5K Followers 2K FollowingRareShare is a social platform building communities for patients, families, and healthcare professionals affected by rare medical disorders.
2K Followers 1K FollowingMPS Society UK is the only registered charity providing professional support to those affected by MPS, Fabry and related diseases.
353 Followers 196 FollowingAustralian & New Zealand Orthopaedic Research Society #ANZORS attracting researchers and clinicians to advance musculoskeletal research
32K Followers 1K FollowingAn alliance of over 1,000 patient organisations working across borders and diseases to improve the lives of all people living with rare diseases.
10K Followers 1K FollowingWe’re the Royal Osteoporosis Society – the UK’s largest national charity dedicated to improving bone health and beating osteoporosis.